SCHEMBL18178739

SCHEMBL18178739

CCC(=O)Oc1ccccc1COc1cc(C)c(C)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.42
PARP10 Q53GL7 2/20 0.41
PARP14 Q460N5 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ACHE P22303 1/20 0.40
ACLY P53396 1/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 4/20 0.38
MRGPRX4 Q96LA9 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MCL1 Q07820 1/20 0.37
AKR1C3 P42330 1/20 0.37
HTT P42858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178543 0.94 PTGDR2 (0.41) PTGDR2PARP10PARP14FFAR4ACHE
SCHEMBL18182843 0.93 PTGDR2 (0.40) PTGDR2PARP10PARP14FFAR4ACHE
SCHEMBL18178643 0.90 PTGDR2 (0.44) PTGDR2PARP10PARP14FFAR4ACHE
SCHEMBL18178751 0.88 PTGDR2 (0.47) PTGDR2FFAR4ACHEMAPK1LMNA
SCHEMBL18183029 0.87 PARP10 (0.41) PTGDR2PARP10PARP14ACLYMAPK1
SCHEMBL18178346 0.87 PARP10 (0.44) PTGDR2PARP10PARP14FFAR4MAPK1
SCHEMBL18178760 0.87 PTGDR2 (0.43) PTGDR2FFAR4ACHEMAPK1LMNA
SCHEMBL18178718 0.86 MRGPRX4 (0.39) ACHEACLYMAPK1ALDH1A1L3MBTL1
SCHEMBL18178575 0.86 PTGDR2 (0.44) PTGDR2PARP10PARP14FFAR4ACHE
SCHEMBL18178441 0.86 MRGPRX4 (0.50) PTGDR2PARP10PARP14FFAR4ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 PTGDR2 4455/4885PARP10 2802/4885PARP14 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.